Moxifloxacin hydrochloride refers to a 4th-generation synthetic antimicrobial agent. It was developed by Bayer AG. Moxifloxacin is sold globally under the trademark names, Avalox, Avelox, Avelon in oral treatments. In majority of the nations across the world, the drug is present in injection form for infusion. It is also available in the form of tablets and marketed as an eye solution under the trademark names, Moxeza and Vigamox.
Browse Full Research Report With TOC on http://www.radiantinsights.com/research/global-moxifloxacin-hydrochloride-tablets-market-research-report-2015
The medicine is adopted as an eye solution to treat conjunctivitis. It varies from the previous antimicrobials of the fluoroquinolone group like ciprofloxacin and levofloxacin. It also shows higher activity against anaerobes and Gram-positive bacteria. This drug showcases strong activity against Streptococcus pneumonia, a pathogen affecting the human respiratory system. For this reason, it is deemed a ‘respiratory quinolone.’
In the United States, these tablets are approved for managing acute bacterial exacerbations of chronic bronchitis, acute bacterial sinus, and community acquired pneumonia. Apart from these, moxifloxacin finds applications in the treatment of complicated intra-abdominal infections and uncomplicated skin structure & skin infections. It has been given green signal by the ‘European Union’ for managing acute bacterial sinus, non-severe community acquired pneumonia, and acute bacterial exacerbations of chronic bronchitis.
Multiple advantages associated with these tablets bode well for the global moxifloxacin hydrochloride tablets market. They have assisted market revenues. The medicine prevents bacterial growth and works effectively. However, it is helpful only in combating bacterial infections and does not work for viral infections. Over or unwanted usage of this drug can lower its effectiveness and generate side effects.
Request A Sample Copy Of This Report at: www.radiantinsights.com/research/global-moxifloxacin-hydrochloride-tablets-market-research-report-2015#tabs-4
Common side effects reported with over, unwanted, or prolonged consumption of moxifloxacin tablets may comprise headache, drowsiness, dizziness, blurred vision, light-headedness, mild diarrhea, and easy sunburns. Furthermore, this drug has certain contraindications and may not go well with other medicines in some cases. Thus, on being prescribed these tablets, patients should consult their doctors to know about their doses, adverse effects, & other aspects.
Some of the contraindications and side effects of the medicine have exposed patients to a variety of health issues. These drawbacks negatively impact the moxifloxacin hydrochloride tablets market and reduce the latter’s earnings. However, steps to ensure that patients don’t suffer in the long run encompass doctor’s advice and patient’s understanding & experience regarding this medicine. If both these steps are implemented, several unpleasant effects of these tablets can be prevented, rendering patients happy.
Browse Reports Of All Category @ http://www.radiantinsights.com/catalogs
Table of Contents
Part I Moxifloxacin Hydrochloride Tablets Industry Overview
Chapter One Moxifloxacin Hydrochloride Tablets Industry Overview
1.1 Moxifloxacin Hydrochloride Tablets Definition
1.2 Moxifloxacin Hydrochloride Tablets Classification Analysis
1.2.1 Moxifloxacin Hydrochloride Tablets Main Classification Analysis
1.2.2 Moxifloxacin Hydrochloride Tablets Main Classification Share Analysis
1.3 Moxifloxacin Hydrochloride Tablets Application Analysis
1.3.1 Moxifloxacin Hydrochloride Tablets Main Application Analysis
1.3.2 Moxifloxacin Hydrochloride Tablets Main Application Share Analysis
1.4 Moxifloxacin Hydrochloride Tablets Industry Chain Structure Analysis
1.5 Moxifloxacin Hydrochloride Tablets Industry Development Overview
1.5.1 Moxifloxacin Hydrochloride Tablets Product History Development Overview
1.5.1 Moxifloxacin Hydrochloride Tablets Product Market Development Overview
1.6 Moxifloxacin Hydrochloride Tablets Global Market Comparison Analysis
1.6.1 Moxifloxacin Hydrochloride Tablets Global Import Market Analysis
1.6.2 Moxifloxacin Hydrochloride Tablets Global Export Market Analysis
1.6.3 Moxifloxacin Hydrochloride Tablets Global Main Region Market Analysis
1.6.4 Moxifloxacin Hydrochloride Tablets Global Market Comparison Analysis
1.6.5 Moxifloxacin Hydrochloride Tablets Global Market Development Trend Analysis
Explore Other Reports By Radiant Insights,Inc at
- Database of the Top 1000 Glass and Glass Product Producers Company –
- Database of the Top 1000 Cement Producers Company –
About Radiant Insight
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic dxecision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States